• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, December 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

PNNL waives fee to test-drive portfolio of intellectual property

Bioengineer by Bioengineer
June 11, 2020
in Science News
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Special exploratory license agreement designed to spur economic recovery

IMAGE

Credit: Andrea Starr | Pacific Northwest National Laboratory

RICHLAND, Wash. — As businesses of all sizes weather today’s tough economy, the U.S. Department of Energy’s Pacific Northwest National Laboratory is offering its entire portfolio of patented technologies on a research trial basis–at no cost–to spur economic development and ultimately create new jobs.

Dozens of technologies could be deployed across U.S. markets spanning everything from analytical instruments, human health and agriculture to advanced manufacturing, cybersecurity and renewable energy. Through the six-month trial period, businesses can try out PNNL’s technologies.

“Our goal is to quickly and inexpensively put these innovations into the hands of companies, entrepreneurs and investors where they can be productized and deployed,” PNNL Director of Technology Deployment and Outreach Lee Cheatham explained.

Some of PNNL’s intellectual property could be applied to help with the COVID-19 pandemic. For example, one of the most recent additions to the portfolio is a coating called ElastiDry. This inexpensive and stretchable superhydrophobic material could be included during the manufacture of latex gloves–or other protective clothing–to make personal protective equipment impenetrable to deadly viruses.

No-cost trial period for on-site testing

From now through December 31, 2020, the standard $1,000 fee will be waived for organizations and entrepreneurs interested in signing a nonexclusive exploratory license agreement, which means more than one organization can hold a license for the same technology. The agreement allows entrepreneurs and organizations to test a technology within their own product lines before entering into a formal licensing agreement.

Details of the special exploratory license agreement include:

  • Use of intellectual property with the option to negotiate a commercial license for the patent; the agreement holds the licensee’s access to intellectual property during the exploratory period.
  • A simplified, two-page form.
  • Simplified terms.
  • Rapid execution–PNNL expects to turn around licenses in less than two weeks.

“As a Department of Energy national laboratory, one of our primary missions is to transfer technologies developed through federal funding to the marketplace, where they can make a real difference,” Cheatham said. “As our nation struggles with how to jump-start our economy, now more than ever, we want to speed the process.”

###

To learn more, visit PNNL’s Exploratory License page.

Media Contact
Tom Rickey
[email protected]

Original Source

https://www.pnnl.gov/news-media/pnnl-waives-fee-test-drive-portfolio-intellectual-property

Tags: Business/EconomicsIntellectual PropertyLicenses/PatentsTechnology Transfer
Share12Tweet8Share2ShareShareShare2

Related Posts

Boosting Cancer Immunotherapy by Targeting DNA Repair

December 3, 2025
blank

Evaluating eGFR Equations in Chinese Children

December 3, 2025

Metformin-Alogliptin Combo vs. Monotherapy in Diabetes

December 3, 2025

Botanical Extracts’ Antibacterial Activity Boosted by Enhancers

December 3, 2025
Please login to join discussion

POPULAR NEWS

  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    204 shares
    Share 82 Tweet 51
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    120 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    107 shares
    Share 43 Tweet 27
  • MoCK2 Kinase Shapes Mitochondrial Dynamics in Rice Fungal Pathogen

    68 shares
    Share 27 Tweet 17

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Boosting Cancer Immunotherapy by Targeting DNA Repair

Evaluating eGFR Equations in Chinese Children

Metformin-Alogliptin Combo vs. Monotherapy in Diabetes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.